Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

Panelists discuss how a woman aged 55 years with T3N1M0 locally advanced squamous cell carcinoma represents a typical case ...

Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...

A panelist discusses how the most effective therapy for squamous cell anal carcinoma is prevention through human papillomavirus vaccination (which may reduce cancer rates in 10-20 years), while ...

Panelists discuss how the evolution of anal cancer treatment began with the 1974 Nigro regimen combining 5-fluorouracil and ...

Total neoadjuvant therapy (TNT) is recommended for locally advanced rectal cancer (LARC) with high-risk factors. The objective of this multi-center phase 2 study is to evaluate the impact of a newly ...

The Concurrent Chemoradiation Paradigm-General Principles Tanguy Y Seiwert; Joseph K Salama; Everett E Vokes Disclosures Nat Clin Pract Oncol. 2007;4 (2):86-100.

Dr. Michael Serzan emphasizes the importance of clinical trial participation for patients with kidney cancer.

The chemoradiotherapy platforms used for the treatment of head and neck cancer are described, together with suggestions about integrating novel agents such as EGFR inhibitors and antiangiogenic drugs.